Literature DB >> 30270399

Autoimmune vertigo: an update on vestibular disorders associated with autoimmune mechanisms.

Francesca Yoshie Russo1, Massimo Ralli1, Daniele De Seta2, Patrizia Mancini1, Alessandro Lambiase1, Marco Artico1, Marco de Vincentiis3, Antonio Greco1.   

Abstract

The role of the immune system in mediating cochleovestibular pathologies has received increasing attention in recent years. Autoimmune vertigo may be an invalidating condition and may worsen the quality of life of affected patients, especially in the cases of delayed diagnosis. Since the etiopathogenesis is still not clear, also the treatment is not yet completely delineated. According to the clinical presentation, autoimmune vertigo can present as an isolated disorder or in association with systemic autoimmune diseases. The main feature in autoimmune vertigo is the presence of an abnormal immune response, in either absence or presence of systemic autoimmune disease, directed against delicate components of the inner ear. This may determine a functional or anatomical alteration, with an inflammatory reaction often devastating for hearing and balance. Being the exact pathogenesis unknown, the diagnosis of autoimmune vertigo is based either on clinical criteria or on a positive response to steroids. The earlier the diagnosis is made, the sooner the therapy can be installed, giving a chance to the recovery of inner ear damages. Corticosteroids represent the most effective and universally accepted treatment, even if other immunomodulatory drugs are now having a more extensive use. HIGHLIGHTS: Vertigo is relatively frequent in autoimmune diseases; however, it is often misdiagnosed or attributed to central nervous system alterations rather to specific inner ear involvement. Vertigo and other audiovestibular symptoms may be the first manifestation of an autoimmune disease and if correctly addressed could significantly contribute to early diagnosis of the underlying autoimmune disease. Early diagnosis of immune-related vertigo can lead to prompt initiation of targeted therapy with elevate chances of preventing irreversible damages to the inner ear. The presence of alternating phases of well-being and disabling symptoms in patients with vertigo should always been considered, as they could suggest an underlying autoimmune condition.

Entities:  

Keywords:  Autoimmunity; Inner ear; Menière disease; Multiple sclerosis; Thyroditis; Vertigo

Mesh:

Substances:

Year:  2018        PMID: 30270399     DOI: 10.1007/s12026-018-9023-6

Source DB:  PubMed          Journal:  Immunol Res        ISSN: 0257-277X            Impact factor:   2.829


  122 in total

1.  Immune-mediated cochleovestibular disease.

Authors:  M Suchan; L Kaliarik; S Krempaska; J Koval
Journal:  Bratisl Lek Listy       Date:  2016       Impact factor: 1.278

2.  Hearing loss associated with systemic lupus erythematosus: temporal bone histopathology.

Authors:  Naomi Fukushima; Hisaki Fukushima; Sebahattin Cureoglu; Patricia A Schachern; Michael M Paparella
Journal:  Otol Neurotol       Date:  2006-01       Impact factor: 2.311

3.  Autoimmune inner ear disease: results of therapy.

Authors:  B F McCabe
Journal:  Adv Otorhinolaryngol       Date:  1991

4.  The relationship between benign paroxysmal positional vertigo and thyroid autoimmunity.

Authors:  Kamran Sari; Tekin Yildirim; Hasan Borekci; Ibrahim Akin; Reha Aydin; Mahmut Ozkiris
Journal:  Acta Otolaryngol       Date:  2015-03-11       Impact factor: 1.494

5.  Inner ear involvement in multiple sclerosis: An underestimated condition?

Authors:  Arianna Di Stadio; Massimo Ralli
Journal:  Mult Scler       Date:  2018-08       Impact factor: 6.312

6.  Intratympanic steroid use for hearing salvage in Vogt-Koyanagi-Harada syndrome.

Authors:  Stanley Pelosi; Sujana S Chandrasekhar
Journal:  Ear Nose Throat J       Date:  2011-12       Impact factor: 1.697

7.  HSP70 antibodies in 80 patients with "clinically certain" Meniere's disease.

Authors:  Jeremy Hornibrook; Peter George; Myfanwy Spellerberg; John Gourley
Journal:  Ann Otol Rhinol Laryngol       Date:  2011-10       Impact factor: 1.547

Review 8.  Revised diagnostic criteria of multiple sclerosis.

Authors:  Ron Milo; Ariel Miller
Journal:  Autoimmun Rev       Date:  2014-01-12       Impact factor: 9.754

9.  Autoantibodies to inner ear and endothelial antigens in Cogan's syndrome.

Authors:  Claudio Lunardi; Caterina Bason; Massimo Leandri; Riccardo Navone; Maurizio Lestani; Enrico Millo; Umberto Benatti; Michele Cilli; Ruggero Beri; Roberto Corrocher; Antonio Puccetti
Journal:  Lancet       Date:  2002-09-21       Impact factor: 79.321

Review 10.  Autoimmune thyroid disease during pregnancy.

Authors:  Simone De Leo; Elizabeth N Pearce
Journal:  Lancet Diabetes Endocrinol       Date:  2017-12-12       Impact factor: 32.069

View more
  8 in total

1.  Editorial: autoimmunity-the ever endless world.

Authors:  Elias Toubi
Journal:  Immunol Res       Date:  2018-12       Impact factor: 2.829

2.  Head-Shaking Nystagmus in the Early Stage of Unilateral Meniere's Disease.

Authors:  Arianna Di Stadio; Giampietro Ricci; Massimo Ralli; Tropiano Paolo; Giovanni Agostini; Mario Faralli
Journal:  J Int Adv Otol       Date:  2019-12       Impact factor: 1.017

3.  Food-induced stimulation of the antisecretory factor to improve symptoms in Meniere's disease: our results.

Authors:  Alfonso Scarpa; Massimo Ralli; Pasquale Viola; Claudia Cassandro; Matteo Alicandri-Ciufelli; Maurizio Iengo; Giuseppe Chiarella; Marco de Vincentiis; Michele Cavaliere; Ettore Cassandro
Journal:  Eur Arch Otorhinolaryngol       Date:  2019-10-11       Impact factor: 2.503

4.  Up-Regulated Expression of Interferon-Gamma, Interleukin-6 and Tumor Necrosis Factor-Alpha in the Endolymphatic Sac of Meniere's Disease Suggesting the Local Inflammatory Response Underlies the Mechanism of This Disease.

Authors:  Chao Huang; Qin Wang; Xueying Pan; Wei Li; Wei Liu; Wenqi Jiang; Li Huang; Anquan Peng; Zhiwen Zhang
Journal:  Front Neurol       Date:  2022-02-23       Impact factor: 4.003

Review 5.  Vestibular Deficits in Deafness: Clinical Presentation, Animal Modeling, and Treatment Solutions.

Authors:  Audrey Maudoux; Sandrine Vitry; Aziz El-Amraoui
Journal:  Front Neurol       Date:  2022-04-04       Impact factor: 4.003

6.  [Hormonal influence on hearing].

Authors:  J M Vahl; E Goldberg-Bockhorn; T K Hoffmann; M C Wigand
Journal:  HNO       Date:  2021-03-16       Impact factor: 1.284

7.  Clinical Characteristics of Patients with Persistent Apogeotropic and Persistent Geotropic Direction-Changing Positional Nystagmus.

Authors:  Lihong Si; Bo Shen; Yuanzhe Li; Xia Ling; Kangzhi Li; Xu Yang
Journal:  J Clin Neurol       Date:  2021-07       Impact factor: 3.077

8.  Autoimmune Vestibulopathy-A Case Series.

Authors:  Surangi Mendis; Nicola Longley; Simon Morley; George Korres; Diego Kaski
Journal:  Brain Sci       Date:  2022-02-24
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.